Drug Shortage Report for 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION
| Report ID | 179915 |
| Drug Identification Number | 00828602 |
| Brand name | 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION |
| Common or Proper name | 0.4% LIDOCAINE HYDROCHLORIDE AND 5% DEXTROSE INJECTION |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE LIDOCAINE HYDROCHLORIDE |
| Strength(s) | 50MG 4MG |
| Dosage form(s) | SOLUTION SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 500mL bag |
| ATC code | C01BB |
| ATC description | ANTIARRHYTHMICS, CLASS I AND III |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2023-01-09 |
| Actual start date | 2023-01-09 |
| Estimated end date | 2023-02-13 |
| Actual end date | 2023-02-13 |
| Shortage status | Resolved |
| Updated date | 2023-02-14 |
| Company comments | Baxter product LIDOCAINE HYDROCHLORIDE 0.4% AND 5% DEXTROSE INJECTION (250 mL bags) is available as a substitute. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2023-02-14 | English | Compare |
| v7 | 2023-02-13 | French | Compare |
| v6 | 2023-02-13 | English | Compare |
| v5 | 2023-02-06 | French | Compare |
| v4 | 2023-02-06 | English | Compare |
| v3 | 2023-01-10 | English | Compare |
| v2 | 2023-01-05 | French | Compare |
| v1 | 2023-01-05 | English | Compare |
Showing 1 to 8 of 8